Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Schistosoma Mansoni
100%
Comparative Proteomic Analysis
100%
Pockmarks
100%
Praziquantel
100%
Distinct Responses
100%
Portugal
100%
Actinomycetes
100%
Pharmacological Potential
100%
Metabolic Profiling
100%
Spur
100%
Metabolite Production
40%
Ikarugamycin
20%
Metabolite Distribution
20%
Chemotaxonomic Markers
20%
EtOAc Extract
20%
Surugamide
20%
Rakicidin
20%
Desferrioxamine
20%
Saccharum Spp
20%
Saccharopolyspora
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Streptomyces
20%
Actinomadura
20%
Marine-derived Actinomycete
20%
Adaptation
20%
North Atlantic
20%
Physostigmine
20%
Metabolic Diversity
20%
Biotechnology
20%
Antimycin A
20%
Molecular Network
20%
Antimicrobial Activity
20%
Chemical Classes
20%
Micromonospora
20%
Nocardiopsis
20%
Antioxidant Activity
20%
16S rRNA Gene Analysis
20%
Verrucosispora
20%
Biosynthetic Potential
20%
Proteome
18%
Schistosoma
18%
Resistance Tolerance
9%
Susceptible Strain
9%
Resistance Trends
9%
Female Adults
9%
In Vitro Study
9%
Neglected Tropical Diseases
9%
Drug Use
9%
Schistosomiasis
9%
Isogenic
9%
Immunology and Microbiology
Schistosoma Mansoni
100%
Proteomics
100%
Praziquantel
100%
Metabolite
100%
Actinobacteria
100%
Schistosoma
18%
Saccharomonospora
16%
Saccharopolyspora
16%
Antimicrobial Agent
16%
Antioxidant Activity
16%
Gene Sequence
16%
Antimicrobial Activity
16%
Nocardiopsis
16%
Tandem Mass Spectrometry
16%
Liquid Chromatography Mass Spectrometry
16%
Actinomadura
16%
Micromonospora
16%
Streptomyces
16%
Ribosomal RNA
16%
In Vitro
9%
Drug Resistance
9%
Schistosomiasis
9%
Transcriptome
9%
Pharmacology, Toxicology and Pharmaceutical Science
Schistosoma Mansoni
100%
Praziquantel
100%
Actinobacteria
100%
Osteophyte
100%
Proteome
18%
Schistosoma
18%
Physostigmine
16%
Deferoxamine
16%
Saccharopolyspora
16%
Ikarugamycin
16%
Saccharomonospora
16%
Antioxidant Capacity
16%
Nocardiopsis
16%
Citrinin
16%
Antiinfective Agent
16%
RNA 16S
16%
Streptomyces
16%
Actinomadura
16%
Micromonospora
16%
Drug Resistance
9%
Tropical Disease
9%
Transcriptome
9%
Diseases
9%
Schistosomiasis
9%